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INTRODUCTION
Microglia are the resident macrophages of the central nervous system (CNS)[1]. The primary function of microglia is 
to survey the CNS microenvironment - monitoring extracellular chemical changes, debris accumulation and pathogen 
invasion[2]. Under normal, unstressed conditions, microglia assume a ramified morphology associated with the 
‘resting’ state of microglia. Following activation by stress or injury, microglia acquire an inflammatory phenotype[3]. 
This includes a shift to amoeboidal morphology, upregulation of surface receptors and production of reactive oxygen 
species and inflammatory cytokines[4-5].   
Microglia are subject to aging and aging-related deterioration of cell function[2]. It has been observed that with 
increasing age, microglia cells assume a state of continuous latent activation[6-9] that leads to an exaggerated glial 
response to injury[10-15]. Reactive microglia are known to be closely associated with locations of pathology in various 
neurodegenerative diseases[11, 12, 16-21]. These in vivo studies on microglia, although not without merit, are compounded 
by the complexity of the CNS microenvironment. An efficient cell culture system would be ideal for scrutiny of age-
related changes in microglia. However, in vitro culture of microglia of adult animals has been limited by the lack of a 
suitable culture system that supports their growth. 
To enhance yield of microglia in culture, growth factors such as granulocyte-macrophage colony stimulating 
factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) have both been shown to promote in vitro 
proliferation of microglia[3, 8-13]. However, as microglia are activated upon stimulus and have differentiation capabilities, 
it is important to ensure that any addition of culture supplement or change to cell culture protocol has minimal effect 
on microglia phenotype. Accordingly, reports have indicated that GM-CSF induces microglia to assume a dendritic 
cell-like phenotype, possibly affecting their immune properties[7, 14]. Although Esen and colleagues demonstrated that 
a dose of 0.5 ng/ml GM-CSF encouraged microglial expansion without significantly altering microglial responses[8], 
they only tested the effects of GM-CSF on resting microglia and did not examine whether the growth factor affects 
the responses of activated microglia.
Ponomarev and colleagues[22] developed a culture system that supports growth of 4-5 week old adult microglia in 
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ABSTRACT
Introduction: The vast majority of in vitro research on microglia are based on cells isolated from 
neonatal animals (3-5 days of age). Studying microglia of adults has been limited by the lack of a suitable 
culture system that supports their growth. In this study, we describe a protocol for growing microglia 
of adults based on modifications of the technique for culturing microglia isolated from neonatal rats. 
Methods: Mixed glia isolated from adult rats (age range of 1 month to 3 years old) were seeded in 
culture flasks coated with poly-L-lysine. Cells were maintained in DMEM media supplemented with 
insulin-transferrin-selenium (ITS) and recombinant human macrophage colony-stimulating factor 
(M-CSF). Mild trypsinisation was carried out to isolate microglia from mixed glia culture. Results: 
Microglia cells of adult rats were successfully grown in vitro. For the expansion of adult microglia, 
it was observed that coating the cell culture flasks with poly-L-lysine was crucial to encourage cell 
adherence. The substitution of insulin in culture media with ITS was found to improve cell yield and 
reduced the number of days required for culture from 28 days to 14 days. Addition of M-CSF to cell 
culture medium, along with the improvisations described above provided the best adult microglia cell 
yield (2.91 ± 0.56 x 106 cells) compared to the technique of replating cells (0.91 ± 0.65 x 106 cells; 
p<0.05). Conclusion: Optimisation of primary cell culture technique by coating culture flasks with 
poly-L-lysine, supplementation of culture medium with ITS and M-CSF allowed microglia of adult rats 
to be successfully cultured in vitro. 
Keywords: Adult microglia, culture, M-CSF 
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culture with the use of M-CSF. They showed that adult microglia supplemented with M-CSF proliferated in culture 
and retained their function. However, it remains to be explored whether use of M-CSF introduces activation artifacts 
for microglia. Previously, we have shown that 20 ng/ml M-CSF improved cell yield of neonatal microglia in culture 
without overt phenotypic changes[23]. The establishment of a cell culture system that supports growth of adult microglia 
would help address our future need to elucidate the effects of aging on microglia responses.
 
MATERIALS AND METHODS
Generation of primary microglia cell cultures
All animal procedures were approved by the Animal Care and Use Committee, Faculty of Medicine and Health 
Sciences, Universiti Putra Malaysia. Microglia were isolated from whole brains of Sprague Dawley rats. Rats within 
the age range of 1 month to 3 years were euthanised using an overdose of carbon dioxide (CO
2
) to obtain mixed glia 
cultures. Briefly, meninges were removed and tissues minced and placed in a 75 cm2 flask, resuspended in 0.25 % 
trypsin-EDTA and 100 U DNase. Cells were then placed in a shaker for 30 minutes at 100 rpm. Supernatant was 
collected and centrifuged at 1200 rpm for 4 minutes. Cells were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10 % heat-inactivated FBS, 1 % Penicillin-Streptomycin, 250 µg/ml Fungizone (all from 
Invitrogen), 1 X insulin-transferrin-selenium (ITS; Sigma–Aldrich) and 20 ng/ml recombinant human M-CSF (R&D 
Systems). Culture medium was changed after 48 hours and subsequently changed every 3 days. 
Mild trypsinisation
Mild trypsinisation was performed as described[24]. Three days following cell confluency (90-100 %), culture medium 
was removed from the flask and stored as ‘conditioned medium’. Cells were washed with PBS and trypsin-EDTA 
solution (0.25 % trypsin, 1 mM EDTA) was added to serum free DMEM in a ratio of 1:3 (v/v). Cells were incubated 
at 37oC for 1 hour. Detached cells were washed away and remaining adherent cells maintained in DMEM media 
supplemented with ITS, M-CSF and ‘conditioned medium’. Cell counts were performed following 60-100 % 
confluency of 75 cm2 cell culture flasks. All cell counts were performed with trypan blue staining as a measure of cell 
viability.
Coating culture flasks with poly-L-lysine or collagen
1 ml of 1 mg/ml poly-L-lysine (Sigma Aldrich) or collagen (extracted from rat tail tendon) was added to T75 
culture flasks and stored at 4oC overnight. Poly-L-lysine/collagen was then aspirated and flasks were left in a 37oC 
incubator overnight to dry completely. Flasks were then washed with phosphate buffered saline (PBS) before cell 
seeding.
Replating non-adherent cells
Cells isolated from adult rats remained afloat although cells had been in culture for several days. Therefore, on the 
second day of culture, media was collected and centrifuged at 1200 rpm for 4 minutes and cells were re-seeded in a 
new poly-L-lysine coated flask.
Lectin staining
Lectin staining was carried out to determine purity of microglia. Briefly, 3.5 x 104 cells were seeded on a 12 mm 
coverslip coated with poly-L-lysine in 24 well plates and left overnight. Media was then removed and the cells were 
fixed with 4 % paraformaldehyde for 20 minutes. Cells were then permeabilised with 0.2 % Triton-X for 5 minutes 
at room temperature and incubated with lectin (1:100 dilution with 1 x PBS, Sigma) for 1 hour at 4oC. Cells were 
counter-stained with DAPI (1: 3000 dilution with ddH
2
O; Invitrogen) and coverslips were mounted on glass slides for 
observation under fluorescence microscope (Olympus BX51).
 
RESULTS
Preparation of primary microglia cell cultures is essentially based on disaggregation of whole brain tissue and the 
culture of the resulting mixed glia culture in a suitable medium. A mild trypsinisation step previously described[24] is 
then performed to isolate microglia from mixed cultures for further propagation. 
We supplement adult microglia cells with M-CSF to promote their in vitro growth. Together with the coating of cell 
culture flasks with a poly-L-lysine matrix and addition of insulin-transferrin-selenium (ITS) to our culture medium, 
we have demonstrated here a culture system that supports in vitro expansion of adult microglia cells. An increase in 
cell yield and decrease in days required for culture were observed when using the devised protocol.
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Cultures consistently demonstrated viability of ≥ 95 %. Although growth of adult cells in culture were made 
possible with the use of poly-L-lysine, cell yield remained low even after 28 days of culture in media supplemented 
with insulin, with a confluency capacity of 60 % (0.36 x 106 cells; Figure 1). Replating non-adherent adult cells into a 
second flask also led to microglia growth after 22 days in culture with a yield of 0.91 ± 0.65 x 106 cells. However, data 
for replated cells were highly variable, indicating inconsistency in this optimisation. Substituting insulin in our cell 
culture media with ITS allowed primary adult microglia cultures to reach confluency faster (17 days) and improved 
cell yield (1.12 ± 0.23 x 106 cells). Supplementation of culture media with both ITS and M-CSF gave the highest cell 
yield (p<.05) with the lowest number of days in culture: 14 days to reach 100 % confluency with a cell yield of 2.91 
± 0.56 x 106.  
Figure 1. Cell yield of adult microglia cultures following various 
technical improvisations. Cell counts were performed 
following 60-100 % confluency. Cells were trypsinised, 
harvested and counted using a haemocytometer. Error bars 
depict ± SD values. Supplementing microglia with both ITS 
and M-CSF significantly increased cell yield compared to 
replated cells (*p<0.05; t-test)
With these optimised conditions, microglia isolated from adult animals can be routinely cultured utilising culture 
flasks coated with poly-L-lysine and culture media supplemented with both ITS and M-CSF. For instance, we were 
able to culture microglia from rats of up to 3 years of age, yielding a mean of 1.95 ± 0.44 x 106 cells per 75 cm2 culture 
flask (Table 1). Lectin staining was performed to allow observation of microglia morphology. Interestingly, adult 
microglia appeared slightly deramified compared to microglia isolated from neonatal rats (Figure 2).
Table 1. Modified protocol allows for culture of adult microglia 
up to 3 years of age. Coating culture flasks with poly-
L-lysine and supplementing culture media with both ITS 
and M-CSF supports growth of adult microglia
Age of rats (months) Days in culture Cell Yield
1-3 14 2.1 x 106
2-4 17 6.4 x 105
2-4 17 7.0 x 105
36 16 7.4 x 105
36 14 3.5 x 106
36 14 3.0 x 106
36 14 3.0 x 106
Mean 1.95 ± 0.44 x 106
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DISCUSSION
Although the activation of microglia following injury appears highly coordinated, there is increasing evidence that this 
organised response is lost with age[25, 26]. Aging microglia are unable to degrade proteins[27], more vulnerable to stress[14] 
and have increased proinflammatory cytokine production[15]. This phenomenon of ‘microglia aging’ is often linked to 
the pathophysiology of various neurological and neurodegenerative diseases[11-14, 17-20]. The lack of a suitable culture 
system that encourages growth of adult microglia has significantly inhibited research in this area. Neonatal microglia 
cells are functionally different from adult, and failure of adult microglia to grow in culture limits the study of aging on 
microglia responses. In this study, we described a method to support in vitro growth of adult microglia.
The basic principle of preparing primary microglia cultures involves mechanical and enzymatic digestion (with 
trypsin) of whole brain tissue. This results in a mixed glia culture which is grown to confluency. To isolate microglia 
from this mixed glia culture, a mild trypsinisation method is used[24]. Briefly, a weak solution of trypsin is added to 
culture flasks to detach astrocytes from the more adherent microglia. The enriched microglia cultures are then further 
propagated in a mixture of DMEM conditioned by mixed glia cultures (termed as ‘conditioned medium’ in Materials 
and Methods). This method is simple, reproducible, and allows preparation of microglia cultures of high purity (> 98 
%) with higher cell yield[24]. 
The protocol for growth of neonatal microglia failed to work for adult cells. In our experience, culture of microglia 
cells isolated from adult animals was previously restricted by their limited mitotic capacity and poor adherence to 
culture flasks. In this study, improvised cell culture techniques were used to support adult microglia cell growth in 
vitro. We have demonstrated that optimisation of the neonatal microglia cell culture technique by coating culture flasks 
with poly-L-lysine and supplementing culture medium with ITS and M-CSF supported adult microglia cell growth in 
vitro. This study was performed with batch-controls, i.e primary microglia cultures, and the BV2 microglia cell line 
were cultivated with/without M-CSF and activated with lipopolysaccharide (LPS), and the active fragment of beta 
amyloid (A
25-35
). 
An initial observation was that adult microglia failed to attach to cell culture flasks, therefore severely inhibiting 
cell proliferation. To encourage adherence, cell culture flasks were coated with poly-L-lysine or collagen (1 mg/ml) 
for 2 hours to overnight at 4oC. However, only poly-L-lysine and not collagen encouraged cell attachment. All adult 
cells were subsequently cultured on poly-L-lysine-coated flasks. Poly-L-lysine is composed of positively charged 
amino acid polymer which enhances electrostatic interaction between negatively charged ions of the cell membrane 
with the culture surface. Although this allows growth of adult cells, cell yield remained low even after many days in 
culture with some cells still remaining unattached to culture flasks. We then decided to re-seed the unattached cells 
into a new culture flask where the cell yield was improved albeit with high variation from flask to flask. Substituting 
insulin in our cell culture media with ITS, further improved cell yield and reduced culture period. ITS is a mixture 
of bovine insulin, human transferrin and sodium selenite. Insulin is a polypeptide hormone that promotes uptake of 
glucose and amino acids by cells. Transferrin is an iron-transport protein and selenium is an essential trace element 
that enhances cell growth[28]. 
The growth factor M-CSF has been known to improve in vitro growth of microglia[9] and is involved in microglia 
proliferation and development[10-12]. Previously we have shown that addition of M-CSF to culture medium enhances 
neonatal microglia proliferation without overtly altering microglia phenotype[23]. Interestingly, proliferation of adult 
microglia was not M-CSF-dependent but poly-L-lysine dependent, i.e. adult cells failed to grow without use of poly-
L-lysine (personal observation). Nonetheless, addition of M-CSF significantly improved cell yield and presented the 
shortest time in culture from all previous modifications described. Interestingly, adult microglia displayed a deramified 
Figure 2. Morphology of cultured microglia cells. Neonatal (A) and adult (B) microglia 
cells were stained with FITC-tagged tomato lectin and DAPI and observed under 
fluorescent microscope (200 X magnification)
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morphology compared to neonatal microglia. This has been linked to age-related morphological changes in microglia 
as adult microglia have a slightly activated phenotype[2].
In conclusion, our study has demonstrated that optimisation of a microglia cell culture technique for neonatal 
cells can support growth of adult microglia in vitro. This includes coating culture flasks with poly-L-lysine and 
supplementation of culture media with ITS and M-CSF.  
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